Table 2.

Treatment-emergent adverse events and key laboratory abnormalities.

Event or Abnormality, n (%) *	Any	Grade ≥ 3
Diarrhea	10 (23.3)	6 (13.9)
Upper respiratory tract infection	7 (16.3)	6 (13.9)
Increased ALT/AST	6 (13.9)	3 (6.9)
Rash	4 (9.3)	1 (2.3)
Pneumonia	3 (6.9)	3 (6.9)
Neutropenia	3 (6.9)	2 (4.7)
Anemia	3 (6.9)	3 (6.9)
Thrombocytopenia	2 (4.7)	2 (4.7)
Mucositis	2 (4.7)	2 (4.7)
Myelodysplastic syndrome	1 (2.3)	1 (2.3)
Pyrexia	1 (2.3)	-
Vomiting	1 (2.3)	1 (2.3)
Total	43	30

ALT—alanine aminotransferase; AST—aspartate aminotransferase. * % are calculated on the total number of AEs, i.e., 43.